Therapeutic Targeting of Pattern Recognition Receptors to Modulate Inflammation in Atherosclerosis

被引:0
|
作者
Su, Hongyan [1 ]
Wang, Xiancheng [1 ]
Wang, Lu [1 ]
Yuan, Na [2 ]
机构
[1] Changchun Univ Chinese Med, Cardiol Dept, Affiliated Hosp 3, Changchun 130000, Peoples R China
[2] Changchun Univ Chinese Med, Rheumatol Dept, Affiliated Hosp, Changchun 30000, Peoples R China
关键词
Atherosclerosis; Cardiovascular diseases; Pattern recognition receptor; Toll-like receptor; LOW-DENSITY-LIPOPROTEIN; NLRP3; INFLAMMASOME; ENDOTHELIAL-CELLS; ATTENUATES ATHEROSCLEROSIS; CIRCULATING MONOCYTES; AIM2; EXPRESSION; CHOLESTEROL; MICE; ACTIVATION;
D O I
10.1007/s12013-024-01481-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atherosclerosis (AS), a potentially fatal cardiovascular disease (CVD), is a chronic inflammatory condition. The disease's onset and progression are influenced by inflammatory and immunological mechanisms. The innate immune pathways are essential in the progression of AS, as they are responsible for detecting first danger signals and causing long-term changes in immune cells. The innate immune system possesses distinct receptors known as pattern recognition receptors (PRRs) which can identify both pathogen-associated molecular patterns and danger-associated molecular signals. Activation of PRRs initiates the inflammatory response in various physiological systems, such as the cardiovascular system. This review specifically examines the contribution of the innate immune response and PRRs to the formation and advancement of AS. Studying the role of these particular receptors in AS would enhance our understanding of the development of AS and offer novel approaches for directly improving the inflammatory response associated with it.
引用
收藏
页码:73 / 86
页数:14
相关论文
共 50 条
  • [41] Liver X Receptors, Atherosclerosis and Inflammation
    Daryn R. Michael
    Tim G. Ashlin
    Melanie L. Buckley
    Dipak P. Ramji
    Current Atherosclerosis Reports, 2012, 14 : 284 - 293
  • [42] The role of complement and pattern recognition receptors in amyloid-beta induced inflammation
    Loizou, F.
    Triantafilou, K.
    Morgan, P. B.
    Triantafilou, M.
    IMMUNOLOGY, 2014, 143 : 114 - 115
  • [43] Therapeutic targeting of chemokine interactions in atherosclerosis
    Koenen, Rory R.
    Weber, Christian
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (02) : 141 - 153
  • [44] Therapeutic targeting of chemokine interactions in atherosclerosis
    Rory R. Koenen
    Christian Weber
    Nature Reviews Drug Discovery, 2010, 9 : 141 - 153
  • [45] Targeting and therapeutic peptides in nanomedicine for atherosclerosis
    Chung, Eun Ji
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (09) : 891 - 898
  • [46] Therapeutic potential of targeting inflammation
    Hamilton, John A.
    INFLAMMATION RESEARCH, 2013, 62 (07) : 653 - 657
  • [47] Therapeutic potential of targeting inflammation
    John A. Hamilton
    Inflammation Research, 2013, 62 : 653 - 657
  • [48] Inflammation in Atherosclerosis: Current Therapeutic Approaches
    Tousoulis, Dimitris
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (37) : 4087 - 4088
  • [49] Host Factors Modulate Virus-Induced IFN Production via Pattern Recognition Receptors
    Wang, Jingjing
    Dong, Yirui
    Zheng, Xuewei
    Ma, Haodi
    Huang, Mengjiao
    Fu, Dongliao
    Liu, Jiangbo
    Yin, Qinan
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3737 - 3752
  • [50] Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis
    Jacotot, Etienne
    Deniaud, Aurelien
    Borgne-Sanchez, Annie
    Touat, Zahia
    Briand, Jean-Paul
    Le Bras, Morgane
    Brenner, Catherine
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2006, 1757 (9-10): : 1312 - 1323